J Coll Physicians Surg Pak
September 2022
Objective: To evaluate the efficacy and safety of zoledronic acid in children with osteogenesis imperfecta (OI).
Study Design: Descriptive Study.
Place And Duration Of Study: National Institute of Child Health, Department of Endocrine and Diabetes, Karachi, Pakistan, from January 2011 to December 2020.